Drug Synergy Prediction via Residual Graph Isomorphism Networks and Attention Mechanisms

• URL: http://arxiv.org/abs/2604.21473v1
• Date: Thu, 23 Apr 2026 09:31:51 GMT
• Title: Drug Synergy Prediction via Residual Graph Isomorphism Networks and Attention Mechanisms
• Abstract summary: We introduce a novel model named the Residual Graph Isomorphism Network integrated with an Attention mechanism (ResGIN-Att)<n>The model first extracts multi scale topological features of drug molecules using a residual graph isomorphism network, where residual connections help mitigate over-smoothing in deep layers. Subsequently, an adaptive Long Short-Term Memory (LSTM) module fuses structural information from local to global scales. Finally, a cross-attention module is designed to explicitly model drug-drug interactions and identify key chemical substructures.
• Score: 3.073484266148604
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: In the treatment of complex diseases, treatment regimens using a single drug often yield limited efficacy and can lead to drug resistance. In contrast, combination drug therapies can significantly improve therapeutic outcomes through synergistic effects. However, experimentally validating all possible drug combinations is prohibitively expensive, underscoring the critical need for efficient computational prediction methods. Although existing approaches based on deep learning and graph neural networks (GNNs) have made considerable progress, challenges remain in reducing structural bias, improving generalization capability, and enhancing model interpretability. To address these limitations, this paper proposes a collaborative prediction graph neural network that integrates molecular structural features and cell-line genomic profiles with drug-drug interactions to enhance the prediction of synergistic effects. We introduce a novel model named the Residual Graph Isomorphism Network integrated with an Attention mechanism (ResGIN-Att). The model first extracts multi scale topological features of drug molecules using a residual graph isomorphism network, where residual connections help mitigate over-smoothing in deep layers. Subsequently, an adaptive Long Short-Term Memory (LSTM) module fuses structural information from local to global scales. Finally, a cross-attention module is designed to explicitly model drug-drug interactions and identify key chemical substructures. Extensive experiments on five public benchmark datasets demonstrate that ResGIN-Att achieves competitive performance, comparing favorably against key baseline methods while exhibiting promising generalization capability and robustness.

Related papers

• Addressing Model Overcomplexity in Drug-Drug Interaction Prediction With Molecular Fingerprints [0.0]
  Accurately predicting drug-drug interactions (DDIs) is crucial for pharmaceutical research and clinical safety.<n>Recent deep learning models often suffer from high computational costs and limited generalization across datasets.<n>In this study, we investigate a simpler yet effective approach using molecular representations such as Morgan fingerprints (S), graph-based embeddings from graph convolutional networks (GCNs), and transformer-derived embeddings from MoLFormer integrated into a straightforward neural network.
  arXiv  Detail & Related papers  (2025-03-30T18:27:01Z)
• A deep graph model for the signed interaction prediction in biological network [1.03121181235382]
  Predicting signed interactions in biological networks is crucial for understanding drug mechanisms and facilitating drug repurposing.<n>textbfRGCNTD is designed to predict both polar (e.g. activation, inhibition) and non-polar (e.g. binding, affect) chemical-gene interactions.<n>We introduce new evaluation metrics, textitAUCtextsubscriptpolarity and textitCP@500, to assess the model's ability to differentiate interaction types.
  arXiv  Detail & Related papers  (2024-07-10T04:28:21Z)
• Benchmark on Drug Target Interaction Modeling from a Structure Perspective [48.60648369785105]
  Drug-target interaction prediction is crucial to drug discovery and design. Recent methods, such as those based on graph neural networks (GNNs) and Transformers, demonstrate exceptional performance across various datasets. We conduct a comprehensive survey and benchmark for drug-target interaction modeling from a structure perspective, via integrating tens of explicit (i.e., GNN-based) and implicit (i.e., Transformer-based) structure learning algorithms.
  arXiv  Detail & Related papers  (2024-07-04T16:56:59Z)
• L-SFAN: Lightweight Spatially-focused Attention Network for Pain Behavior Detection [44.016805074560295]
  Chronic Low Back Pain (CLBP) afflicts millions globally, significantly impacting individuals' well-being and imposing economic burdens on healthcare systems. While artificial intelligence (AI) and deep learning offer promising avenues for analyzing pain-related behaviors to improve rehabilitation strategies, current models, including convolutional neural networks (CNNs), have limitations. We introduce hbox EmoL-SFAN, a lightweight CNN architecture incorporating 2D filters designed to capture the spatial-temporal interplay of data from motion capture and surface electromyography sensors.
  arXiv  Detail & Related papers  (2024-06-07T12:01:37Z)
• Learning to Denoise Biomedical Knowledge Graph for Robust Molecular Interaction Prediction [50.7901190642594]
  We propose BioKDN (Biomedical Knowledge Graph Denoising Network) for robust molecular interaction prediction. BioKDN refines the reliable structure of local subgraphs by denoising noisy links in a learnable manner. It maintains consistent and robust semantics by smoothing relations around the target interaction.
  arXiv  Detail & Related papers  (2023-12-09T07:08:00Z)
• Brain Imaging-to-Graph Generation using Adversarial Hierarchical Diffusion Models for MCI Causality Analysis [44.45598796591008]
  Brain imaging-to-graph generation (BIGG) framework is proposed to map functional magnetic resonance imaging (fMRI) into effective connectivity for mild cognitive impairment analysis. The hierarchical transformers in the generator are designed to estimate the noise at multiple scales. Evaluations of the ADNI dataset demonstrate the feasibility and efficacy of the proposed model.
  arXiv  Detail & Related papers  (2023-05-18T06:54:56Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• Interpreting the Mechanism of Synergism for Drug Combinations Using Attention-Based Hierarchical Graph Pooling [10.898133007285638]
  We develop an interpretable graph neural network (GNN) that reveals the underlying essential therapeutic targets and the mechanism of the synergy (MoS) The proposed GNN model provides a systematic way to predict and interpret the drug combination synergism based on the detected crucial sub-molecular network.
  arXiv  Detail & Related papers  (2022-09-19T11:18:45Z)
• Hierarchical Graph Representation Learning for the Prediction of Drug-Target Binding Affinity [7.023929372010717]
  We propose a novel hierarchical graph representation learning model for the drug-target binding affinity prediction, namely HGRL-DTA. In this paper, we adopt a message broadcasting mechanism to integrate the hierarchical representations learned from the global-level affinity graph and the local-level molecular graph. Besides, we design a similarity-based embedding map to solve the cold start problem of inferring representations for unseen drugs and targets.
  arXiv  Detail & Related papers  (2022-03-22T04:50:16Z)
• MOOMIN: Deep Molecular Omics Network for Anti-Cancer Drug Combination Therapy [2.446672595462589]
  We propose a multimodal graph neural network that can predict the synergistic effect of drug combinations for cancer treatment. Our model captures the representation based on the context of drugs at multiple scales based on a drug-protein interaction network and metadata. We demonstrate that the model makes high-quality predictions over a wide range of cancer cell line tissues.
  arXiv  Detail & Related papers  (2021-10-28T13:10:25Z)
• Improved Drug-target Interaction Prediction with Intermolecular Graph Transformer [98.8319016075089]
  We propose a novel approach to model intermolecular information with a three-way Transformer-based architecture. Intermolecular Graph Transformer (IGT) outperforms state-of-the-art approaches by 9.1% and 20.5% over the second best for binding activity and binding pose prediction respectively. IGT exhibits promising drug screening ability against SARS-CoV-2 by identifying 83.1% active drugs that have been validated by wet-lab experiments with near-native predicted binding poses.
  arXiv  Detail & Related papers  (2021-10-14T13:28:02Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.